A prospective randomized safety trial of celecoxib for treatment of preterm labor

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 3, 2002, Pages 653-660

  Stika, Catherine S ^a   Gross, Gilad A ^b   Leguizamon, Gustavo ^b   Gerber, Susan ^a   Levy, Roni ^b   Mathur, Amit ^b   Bernhard, Lisa M ^b   Nelson, D Michael ^b   Sadovsky, Yoel ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Celecoxib; Cyclo oxygenase; Indomethacin; Preterm labor

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MAGNESIUM SULFATE; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DUCTUS ARTERIOSUS; FEMALE; FETUS ECHOGRAPHY; FLOW RATE; HUMAN; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOCOLYSIS;

EID: 0036739034     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.125281     Document Type: Article

References (25)

1. Kelly RW. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994;15:684-706.
2. Kniss DA. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Investig 1999;6:285-92.
3. Sadovsky Y, Nelson DM, Muglia LJ, Gross GA, Harris KC, Koki A, et al. Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. Am J Obstet Gynecol 2000;182:370-6.
4. Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and-2. Adv Immunol 1996;62:167-215.
5. Mijovic JE, Zakar T, Angelova J, Olson DM. Prostaglandin endoperoxide H synthase mRNA expression in the human amnion and decidua during pregnancy and in the amnion at preterm labour. Mol Hum Reprod 1999;5:182-7.
6. Mijovic JE, Zakar T, Nairn TK, Olson DM. Prostaglandin endoperoxide H synthase (PGHS) activity and PGHS-1 and -2 messenger ribonucleic acid abundance in human chorion throughout gestation and with preterm labor. J Clin Endocrinol Metab 1998;83:1358-67.
7. Leguizamon G, Smith J, Younis H, Nelson DM, Sadovsky Y. Enhancement of amniotic cyclooxygenase type 2 activity in women with preterm delivery associated with twins or polyhydramnios. Am J Obstet Gynecol 2001;184:117-22.
8. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin: part II, double-blind study. J Perinat Med 1984;12:25-9.
9. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980;136:1014-9.
10. Higby K, Xenakis EM-J, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59.
11. Kirshon B, Moise KJ Jr, Wasserstrum N, Ou CN, Huhta JC. Influence of short-term indomethacin therapy on fetal urine output. Obstet Gynecol 1988;72:51-3.
12. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
13. Moise KJ Jr, Huhta JC, Sharif DS, Ou CN, Kirshon B, Wasserstrum N, et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 1988;319:327-31.
14. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-42.
15. Carlan SJ, O'Brien WF, O'Leary TD, Mastrogiannis D. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992; 79:223-8.
16. Smith GCS. The pharmacology of the ductus arteriosus. Pharmacol Rev 1998;50:35-58.
17. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995;83:473-82.
18. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995;83:483-92.
19. Peri KG, Hardy P, Li DY, Varma DR, Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem 1995;41:24615-20.
20. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a β-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 1991;164:141-6.
21. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, et al. Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol 2000;278:R1415-23.
22. Guerguerian A-M, Hardy P, Bhattacharya M, Olley P, Clyman RI, Fouron J-C, et al. Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs. Am J Obstet Gynecol 1998; 179:1618-26.
23. Takahashi Y, Roman C, Chemtob S, Tse MM, Lin E, Heymann MA, et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 2000;278:R1496-505.
24. Holmes RP, Stone PR. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 2000; 96:810-1.
25. Locatelli A, Vergani P, Bellini P, Strobelt N, Ghidini A. Can a cyclooxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? Br J Obstet Gynaecol 2001;108:325-6.